CHEMO BRAIN (Cancer Therapy)
- A Beautiful Mind Psychology and Psychotherapy Clinic
CHEMO BRAIN (Cancer Therapy)
The Effect of EEG Biofeedback on Reducing Postcancer Cognitive Impairment
Jean Alvarez, EdD, Fremonta L. Meyer, David L. Granoff and Allan Lundy.
Postcancer cognitive impairment (PCCI) is observed in a substantial number of breast cancer survivors, persisting for as long as 20 years in some subgroups. Although compensatory strategies are frequently suggested, no restorative interventions have yet been identified. This study examined the feasibility of EEG biofeedback (“neurofeedback”) and its potential effectiveness in reducing PCCI as well as the fatigue, sleep disturbance, and psychological symptoms that frequently accompany PCCI.
Efficacy of EEG Biofeedback in Addressing Cognitive Dysfunction in Cancer Survivors
This study examined the efficacy of EEG biofeedback (neurofeedback) in addressing the cognitive sequelae of cancer therapy, commonly known as “chemobrain” or “chemofog.” Approximately fifty percent of breast cancer survivors exhibit cognitive impairment within three weeks of beginning chemotherapy, and half of those have not recovered one year later. Neurofeedback, unlike compensatory strategies currently recommended by the National Cancer Institute and major cancer centers, has the potential to restore cognitive function.
Jean Alvarez, EdD, David L. Granoff, Allan Lundy